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Parkinson’s disease (PD) is the second most common neurode-
generative disease, after Alzheimer’s disease.1 The prevalence of PD
is rising, currently affecting 1 million people in the United States,
and approximately 50,000 new cases are reported there annually.2
In Taiwan, the prevalence was 340 per 105 people, and the inci-
dence rate was 345.46 per 105 people in 2004.3 PD is a multisystem
disorder involving the dopaminergic, noradrenergic, serotonergic,
and cholinergic systems and is characterized by motor and non-
motor symptoms.4 A large proportion of patients with PD present
with lower urinary tract dysfunction (LUTD) including urgency,
increased frequency, and incontinence as predominant symptoms.
LUTD is a prominent autonomic feature of PD and is both
troublesome and a cause of morbidity in patients with the disease.
Recent advances in investigative neurology provided insights into
the underlying pathophysiology and appropriate management of
urinary dysfunction.5 Urinary symptoms were shown to be statis-
tically correlated with the severity of PD, but not with the duration
of illness or in sexual differences.6 A videourodynamic study
(VUDS) provides useful information according to our clinical
practice, including details of the urethral sphincter and detrusor
activity.5 Urethral sphincter pseudodyssynergia is a phenomenon
in which the external urethral sphincter contracts at the initiation
of urination in patients without spinal cord injury. Detrusor over-
activity (DO) is frequently noted in these patients. Most patients
have subsequent urethral sphincter relaxation and initiation ofBuddhist Tzu Chi General
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ciation. Published by Elsevier Taiwurination. Intermittent urethral sphincter activities can also occur
during urination and result in considerable postvoiding residual
(PVR) urine. In some aspects, pseudodyssynergia is similar to
detrusor sphincter dyssynergia type 1; the main difference
between them is the neurological deﬁcit seen in detrusor sphincter
dyssynergia that occurs in patients with spinal cord injury.2. Urodynamic characteristics and interpretation
Patients with PD may present with normal voiding, DO, and
dyskinesia of the urethral sphincter.
In the ﬁrst case, a 72-year-old man was diagnosed with PD
5 years earlier; however, lower urinary tract symptoms (LUTSs)
became exacerbated during the year before presentation. A digital
rectal examination revealed a moderately enlarged prostate
without a hard nodule. Transrectal sonography of the prostate
showed a total prostatic volume of 36 mL with a transition zone
index of 0.3. A VUDS revealed DO (Fig. 1). The urethral sphincter
showed increased activity, and voiding detrusor pressure (Pdet) was
high and poorly sustained when the patient had the urge to void.
Although the detrusor contracted and urine began to ﬂow, the
patient’s sphincter did not relax for approximately 2 minutes.
Voiding cystourethrography showed a narrow urethral sphincter
during voiding. DO and dyskinetic urethral sphincter activity
constitute urethral sphincter pseudodyssynergia during voiding,
seen clinically as urgency and dysuria.
In a second case, a 75-year-old woman with a 3-year history of
PD presented with progressive frequency, urgency, and urgency
urinary incontinence for 1 year. A trial with an antimuscarinic agent
was unsuccessful. She did not have dysuria or miction pain;
however, she complained of constipation after antimuscarinic
therapy. Urinalysis and cystoscopy revealed no abnormalities.an LLC. Open access under CC BY-NC-ND license.
Fig. 1. Videourodynamic study revealed detrusor overactivity elicited at a volume of 108 mL (arrow 1). When the patient had the urge to void, the sphincter showed a further
increase in activity, and the detrusor pressure (Pdet) was high and poorly sustained (arrowheads 2). After 2 minutes of detrusor contraction, the sphincter began to relax and urine
started to ﬂow at a Pdet lower than the maximal Pdet (arrows 3). Pdet at the maximum ﬂow rate (Qmax) was 32 cmH2O, Qmax was 14 mL/s, and the postvoiding residual was minimal.
Voiding cystourethrography showed the bladder neck, a patent prostatic urethra, and a narrow urethral sphincter during voiding (arrows 4).
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when the bladder was almost full and further increased when an
involuntary detrusor contraction occurred (Fig. 2). When the
patient relaxed the urethral sphincter, uroﬂow began, and the
maximum ﬂow rate (Qmax) usually occurred at a Pdet lower than the
maximal voiding pressure.
In a ﬁnal case, a 63-year-old woman with a 5-year history of
PD complained of urinary incontinence, difﬁcult urination, and
residual urine sensation. Symptoms had worsened over severalFig. 2. The ﬁrst sensation of bladder ﬁlling was perceived at a volume of 120 mL, and urge se
was noted when the bladder was almost full (arrowheads). The sphincter EMG activities
pressure was 35 cmH2O, but the detrusor pressure (Pdet) at the maximum ﬂow rate (Qmax) w
voiding, the bladder neck and urethra were open, and the bladder wall was smooth (arrowmonths before presentation. Cystoscopy revealed a normal-
appearing bladder and urethra. Urinalysis showed no abnormal
ﬁndings. Transrectal sonography showed no bladder base hyper-
mobility during coughing and straining. A VUDS showed unin-
hibited detrusor contractions, and urethral sphincter EMG activity
increased with increasing bladder volume until the maximal
voiding pressure was reached when the urethral sphincter
relaxed. During the voiding phase, the bladder neck and proximal
urethra were widely opened, but the middle urethra wasnsation began at 180 mL. Increased urethral sphincter electromyography (EMG) activity
further increased when detrusor contraction began (arrows 1). The maximal voiding
as only 20 cmH2O. The Qmax was 9 mL/s, and the voided volume was 202 mL. During
s 2).
Fig. 3. Uninhibited detrusor contractions occurred at a bladder capacity of 83 mL. Urethral sphincter electromyographic activity increased with an increasing bladder volume until
the maximal voiding pressure was reached when the urethral sphincter relaxed (large arrows). The voiding pressure was high (61 cmH2O), and the maximum ﬂow rate (Qmax) was
low (7 mL/s). During the voiding phase, the bladder neck and proximal urethra were wide open, but the middle urethra was relatively narrow (arrowheads). The postvoiding
residual volume was 100 mL. Intermittent urethral sphincter activities were also noted during the voiding phase. A high voiding pressure with a low maximum ﬂow rate was noted
(small arrows).
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were also noted during the voiding phase (Fig. 3). Urethral
sphincter pseudodyssynergia was characterized by a high Pdet,
low Qmax, and increased urethral sphincter activity during the
voiding phase; the patient usually had a large PVR after inter-
ruption of urination.
3. Discussion
The presence of voiding dysfunction in PD patients was reported
in several studies with an incidence of 37e71%.6 Voiding dysfunc-
tion occurs when the extrapyramidal system is impaired. A
previous investigation showed that 40e70% of patients with PD
have some degree of voiding dysfunction, and nearly 70% have
irritative bladder symptoms.7 DO was the predominant urody-
namic ﬁnding, which may explain the LUTSs in patients with PD.
Pseudodyssynergia existed in 25e60% of patients with PD.8 All
three cases reported here presented with pseudodyssynergia and
were found to have high-pressure voiding followed by sphincter
relaxation.
Most patients with pseudodyssynergia have frequency, urgency,
and dysuria; however, urgency and urinary incontinence without
dysuria are also observed, as in the second case presented here. The
key ﬁndings of pseudodyssynergia in the VUDS are increased
voiding pressure and sphincter activity with initiation of urination
followed by sphincter relaxation and the start of urine ﬂow. During
urination, sphincter activity can be silent or intermittent. Skeletal
muscle tone is regulated by a spinal reﬂex arc (gamma loop), which
may be exaggerated with an extrapyramidal neurological lesion.8
Impaired sphincter coordination or poor relaxation of the pelvic-
ﬂoor muscle can be the result of increased excitability of gamma
neurons in PD. It was postulated that this bradykinetic phenom-
enon may be related to disease severity in patients with PD.
Patients with PDwho have a hyperactive urethral sphincter may
be unable to adequately relax the urethral sphincter during voli-
tional or reﬂex micturition, resulting in inadequate detrusorcontractility and an increased PVR volume.9 In consideration of this
factor, treatment with medication to relax the urethral sphincter
might provide relief to patients with LUTSs.
Detrusor instability and bladder outlet obstruction are common
in men with LUTSs.10 Treatment targeting benign prostatic hyper-
plasia is usually unsuccessful in relieving LUTSs in patients with PD,
especially those who have not undergone a urodynamic study.
Treatment of urodynamic symptoms should be aimed at relaxing
the urethral sphincter. Medication with antimuscarinics for DO
along with skeletal muscle relaxants can be helpful. If medications
fail or if the patient cannot tolerate the adverse effects of anti-
muscarinics, such as constipation, blurred vision, dry mouth, and
impaired cognitive function, treatment with a urethral sphincter
botulinum toxin A injection is the next therapeutic step and can
provide a good therapeutic effect.11,12 Surgical intervention for
benign prostatic hyperplasia is contraindicated in patients without
a deﬁnite evidence of bladder outlet obstruction.
4. Conclusions
DO is the main urodynamic ﬁnding in PD patients with LUTSs. A
hyperactive urethral sphincter with pseudodyssynergia causes an
increased PVR volume in some patients. A VUDS can aid in dis-
tinguishing the pathophysiology of voiding dysfunction in patients
with PD. Treatment of PD and LUTSs should be based on underlying
bladder and urethral sphincter dysfunctions.
Conﬂicts of interest statement
The authors declare that they have no ﬁnancial or non-ﬁnancial
conﬂicts of interest related to the subject matter or materials dis-
cussed in the manuscript.
Source of Funding
None.
C.-H. Kuei et al. / Urological Science 23 (2012) 120e123 123References
1. Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, Bruley des Varannes S,
Neunlist M, et al. The second brain and Parkinson’s disease. Eur J Neurosci
2009;30:735e41.
2. Lang AE, Lozano AM. Parkinson’s disease: ﬁrst of two parts. New Engl J Med
1998;339:1044e53.
3. Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL. Ageing and neurodegenerative
disease. Ageing Res Rev 2010;9:S36e46.
4. Awad RA. Neurogenic bowel dysfunction in patients with spinal cord injury,
myelomeningocele, multiplesclerosis and Parkinson’s disease. World J Gastro-
enterol 2011;17:5035e48.
5. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and
sphincter motor unit potential analyses in Parkinson’s disease and multiple
system atrophy. J Neurol Neurosurg Psychiatry 2001;71:600e6.6. Hattori T, Yasuda K, Kita K, Hirayama K. Voiding dysfunction in Parkinson’s
disease. J Psychiatry Neurol 1992;46:181e6.
7. Murnaghan GF. Neurogenic disorders of the bladder in parkinsonism. Br J Urol
1961;33:403e9.
8. Pavlakis AJ, Siroky MB, Goldstein I, Krane RJ. Neurourologic ﬁndings in Par-
kinson’s disease. J Urol 1983;129:80e3.
9. Jenkina TW. Functional mammalian neuroanatomy: with emphasis on the dog
and cat, including an atlas of the central nervous system of the dog. 2nd ed.
Philadelphia, PA: Lea & Febiger; 1978. p. 131.
10. Wang SN, Kuo HC. Videourodynamic ﬁndings in Parkinson’s disease. J Taiwan
Urol Assoc 2007;18:23e6.
11. Hyman MJ, Groutz A, Blaivas JG. Detrusor instability in men: correlation of lower
urinary tract symptoms with urodynamic ﬁndings. J Urol 2001;166:550e3.
12. Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for
voiding disorders: current state of the art. Eur Urol 2003;44:165e74.
